Milestone Pharmaceuticals Inc. (MIST)
Last updated: 2026-10-24 12:03:00. Prices reflect the latest closing data and will resume updating on the next trading day. Stock price data is sourced from Massive.
Summary
Milestone Pharmaceuticals Inc. (MIST) operates in the PHARMACEUTICAL PREPARATIONS sector and is listed on NASDAQ. The stock is currently priced at $0.65, with a market capitalization of $87.48M and a P/E ratio of --. Over the past 52 weeks, its price has ranged from $0.63 to $3.06. This page covers its latest market performance, valuation, price trends and company information.
Key Market Data
$87.48M | |
$0.71 | |
$27.95 | |
$0.63 | |
$0.70 | |
1.49M | |
1.43M | |
-- | |
$3.06 | |
$0.63 | |
-- | |
-- |
Milestone Pharmaceuticals Inc. (MIST) Latest Closing Stock Price
Milestone Pharmaceuticals Inc. (MIST) last closed at $0.70 as of 2026-10-24 00:00:00, unchanged from the previous close of $0.70.
During the latest regular trading session, MIST traded between $0.63 and $27.95, with a volume of 1.49M shares. The closing price was near the lower end and near the lower end of its 52-week range.
Milestone Pharmaceuticals Inc. (MIST) 7-Day Stock Price Change
Over the past seven days, Milestone Pharmaceuticals Inc. (MIST) moved from $0.79 to $0.65, representing a decline of 18.69% ($0.15).
The stock traded between $0.63 and $0.80 during the period. The latest price is near the lower end of the 7-day range, indicating strong downward.
The average daily volume was 865.81 thousand shares, down versus the previous seven-day period, indicating lower trading activity.
MIST 52-Week Price Position
Position in Range: 0.5%
MIST is currently trading at $0.65, placing it 0.5% of the way from its 52-week low of $0.63 to its 52-week high of $3.06. This percentage reflects the stock's relative position within its 52-week trading range, not its valuation or future performance.
What is Milestone Pharmaceuticals Inc. (MIST)?
Milestone Pharmaceuticals Inc is a biopharmaceutical company focused on the development and commercialization of cardiovascular medicines. Its approved product CARDAMYST (etripamil) nasal spray is available in the United States and is the self-administered treatment for use by patients anywhere, anytime an attack of PSVT occurs. It operates in single segment.
Milestone Pharmaceuticals Inc. Information
| Industry | PHARMACEUTICAL PREPARATIONS |
| Employees | 38 |
| Exchange | NASDAQ |
| Company Website |
How to Buy Milestone Pharmaceuticals Inc. (MIST) Stock on MEXC
Eligible investors can buy real shares of Milestone Pharmaceuticals Inc. (MIST) through MEXC RealStocks. Follow these three steps to open a RealStocks account, transfer USDT, and place a US stock order.
Frequently Asked Questions (FAQ)
1.What is Milestone Pharmaceuticals Inc. (MIST) stock price today?
2.Is MIST stock going up or down today?
3.What is MIST pre-market price?
4.What is MIST after-hours price?
5.Is MIST stock trading now?
6.Where does MIST sit relative to its 52-week high and low?
7.What sector is Milestone Pharmaceuticals Inc. in?
8.What is Milestone Pharmaceuticals Inc.'s market capitalization and where is it listed?
9.How is MIST valued in terms of P/E ratio and EPS?
10.Does Milestone Pharmaceuticals Inc. pay a dividend?
Explore More US Stocks
Search Stocks
MIST Stock Calculator
Estimate the value between MIST shares and USD.
MIST Shares to USD
1.00 MIST shares = 0.646 USD
Calculations are estimates based on the latest available price and are for reference only.


